Song Li Pharmaceutical-B (01672) will present data from multiple projects at the American Diabetes Association 2026 Scientific Conference.

SMART Finance APP News, GeLi Pharmaceutical-B (01672) issued an announcement that it will showcase multiple projects in the form of posters at the American Diabetes Association (ADA) 2026 Annual Scientific Meeting in New Orleans, Louisiana from June 5th to 8th, 2026. The showcase will include preclinical data for ASC39 (a selective and potent oral small molecule insulin receptor agonist similar to eloralintide used for treating obesity), which has been selected as a late-breaking poster for the latest breakthrough.